PANACEA BIOTEC
Back to Balance Sheet
|
PANACEA BIOTEC Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹367 Cr | ₹369 Cr | ₹656 Cr | ₹368 Cr | ₹407 Cr |
What is the latest Contingent Liabilities ratio of PANACEA BIOTEC ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹367 Cr |
| Mar2024 | ₹369 Cr |
| Mar2023 | ₹656 Cr |
| Mar2022 | ₹368 Cr |
| Mar2021 | ₹407 Cr |
How is Contingent Liabilities of PANACEA BIOTEC Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹367 Cr | -0.62 | |
| Mar2024 | ₹369 Cr | -43.67 | |
| Mar2023 | ₹656 Cr | 78.11 | |
| Mar2022 | ₹368 Cr | -9.54 | |
| Mar2021 | ₹407 Cr | - | |
Compare Contingent Liabilities of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹2,568.8 Cr | -1.2% | -21.8% | 4.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | -1.2% |
-21.8% |
4.7% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses